clinical trials

1b, or not 1b: FDA hits Viking with clinical hold over mix-up in phase of rare disease trial
Fierce Biotech
Mon, 01/24/22 - 10:19 am
Viking Therapeutics
clinical trials
FDA
VK0214
metabolic disorders
MaaT wraps up cancer microbiome trial early to power into phase 2/3 this year
Fierce Biotech
Mon, 01/24/22 - 10:14 am
MaaT Pharma
microbiome
clinical trials
AML
3 Clinical Trials to Watch in the First Half of 2022
Motley Fool
Sat, 01/22/22 - 02:20 pm
clinical trials
Pfizer
Arena Pharmaceuticals
etrasimod
Roche
Alzheimer's disease
gantenerumab
AbbVie
cystic fibrosis
Roche sees cause for optimism with failed Huntington's disease drug. Others aren't so sure.
BioPharma Dive
Sat, 01/22/22 - 02:18 pm
Roche
clinical trials
Huntington's disease
Confidence is high for Eli Lilly CEO Ricks in showdown with Biogen's Aduhelm
Fierce Biotech
Fri, 01/21/22 - 11:13 am
Eli Lilly
Biogen
Alzheimer's disease
Aduhelm
donanemab
clinical trials
David Ricks
This Week at FDA: Generic drug approvals continue downward trend, new guidance on clinical trial diversity coming
RAPS.org
Fri, 01/21/22 - 11:01 am
FDA
regulatory
clinical trials
clinical trial diversity
generics
Exact Sciences posts positive data on Cologuard 2.0 ahead of readouts on rival tests
Medtech Dive
Thu, 01/20/22 - 10:55 am
diagnostics
Medtech
EXACT Sciences
Cologuard 2.0
clinical trials
colon cancer
CROs embracing tech to decentralize trials and speed enrollment as regulators show support 'with their feet'
Fierce Biotech
Thu, 01/20/22 - 10:48 am
CROs
clinical trials
decentralized clinical trials
With $825M SPAC merger, ProKidney sets stage for phase 3 trial of kidney disease cell therapy
Fierce Biotech
Tue, 01/18/22 - 11:58 pm
ProKidney
SPACs
cell therapy
clinical trials
kidney disease
Europe launches initiative to transform clinical trials
Biopharma Reporter
Tue, 01/18/22 - 10:41 am
Europe
clinical trials
Rewind: Roche returns to phase 2 after seeing post hoc signal in failed pivotal Huntington's trial
Fierce Biotech
Tue, 01/18/22 - 10:30 am
Roche
Ionis Pharmaceuticals
tominersen
Huntington's disease
clinical trials
Tiny biotech hammered as lead drug fails a key PhII study
Endpoints
Tue, 01/18/22 - 10:28 am
Sensorion
clinical trials
France
arazasetron
hearing loss
FDA approval, global partnership on the agenda at Mithra as phase 3 menopause trials hit goals—with one blemish
Fierce Biotech
Fri, 01/14/22 - 11:18 am
Mithra
clinical trials
menopause
FDA
hot flashes
EMA sets out plan to accelerate clinical trials, reduce administrative burden
Fierce Biotech
Fri, 01/14/22 - 11:16 am
EMA
Europe
clinical trials
CRO owner pleads guilty to obstructing FDA investigation into falsified clinical trial data
Endpoints
Thu, 01/13/22 - 11:01 am
legal
CROs
GSK
clinical trials
falsified data
For Biogen's Aduhelm, narrow coverage from CMS 'could effectively spell the end': analyst
Fierce Pharma
Wed, 01/12/22 - 11:01 am
CMS
Biogen
Aduhelm
Medicare
clinical trials
Alzheimer's disease
Chasing Roche, Merck unveils adjuvant lung cancer data for Keytruda
Pharmaforum
Tue, 01/11/22 - 11:28 am
Merck
Roche
Keytruda
clinical trials
non-small cell lung cancer
Tecentriq
Novartis snaps up the rights to a Covid-19 antiviral after seeing mid-stage results. So where are the data?
Endpoints
Mon, 01/10/22 - 11:31 pm
Novartis
Molecular Partners
clinical trials
COVID-19
antivirals
ensovibep
BioMarin's hemophilia A gene therapy hits goal in phase 3, teeing up FDA filing despite durability doubts
Fierce Biotech
Mon, 01/10/22 - 11:32 am
Biomarin
hemophilia A
gene therapy
valrox
clinical trials
Where Will Cassava Sciences Be in 1 Year?
Motley Fool
Fri, 01/7/22 - 10:45 am
Cassava Sciences
Simulfilam
clinical trials
Alzheimer's disease

Pages